Gilead Sciences Acquires Calistoga Pharmaceuticals for $375,000,000

  • Feed Type
  • Date
  • Company Name
    Calistoga Pharmaceuticals
  • Mailing Address
    2101 – 4th Avenue Seattle, WA 98121
  • Company Description
    Calistoga Pharmaceuticals, is developing a drug candidate acquired from Icos that has potential to treat various forms of cancer.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Calistoga could earn up to an additional $225 million if certain milestones are achieved.

By posting a comment, you agree to our terms and conditions.